Current Report Filing (8-k)
October 14 2021 - 5:17PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d)
of
the Securities Exchange Act of 1934
Date
of Report (date of earliest event reported): October 14, 2021
LEGACY
VENTURES INTERNATIONAL, INC.
(Exact
Name of Registrant as Specified in its Charter)
Nevada
|
|
000-55849
|
|
30-0826318
|
(State
of incorporation)
|
|
(Commission
File Number)
|
|
(IRS
Employer Identification No.)
|
27
Baycliffe Rd. Markham
|
|
ON,
L3R 7T9
|
(Address
of principal executive offices)
|
|
(Zip
Code)
|
(647)
969-7383
(Registrant’s
telephone number, including area code)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):
☐
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
|
Emerging
growth company ☐
|
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Securities
registered under Section 12(g) of the Exchange Act:
Title
of each class
|
|
Trading
Symbol(s)
|
|
Name
of each exchange on which
registered
|
Common
Stock, $.0001 par value per share
|
|
LGYV
|
|
N/A
|
Securities
registered pursuant to Section 12(b) of the Act: None
Item
5.01 Changes in Control of Registrant.
On
October 14, 2021, as a result of a private transactions, 286,720 shares of common stock, $0.0001 par value per share (the “Shares”)
of Legacy Ventures International, Inc., a Nevada corporation (the “Company”), were transferred from Peter Sohn to Ying Feng
LAI, Wei TJONG, Pak Hong WAN, Johnathan Chung Hon CHOI, Chi Hung YEUNG, and Hau Ming CHOW (together, the “Purchasers”). As
a result, the Purchasers became holders of approximately 91% of the voting rights of the issued and outstanding share capital of the
Company on a fully-diluted basis of the Company, and became the controlling shareholders. The consideration paid for the Shares was $480,000.
The source of the cash consideration for the Shares was personal funds of the Purchaser. In connection with the transaction, Peter Sohn
released the Company from all debts, and all promissory notes and convertible notes payable were canceled.
Other
than as described below, there are no arrangements or understandings among both the former and new control persons and their associates
with respect to the election of directors of the Company or other matters. The information set forth in Item 5.02 of this Form 8-K is
incorporated by reference into this Item 5.01.
Item
5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of
Certain Officers.
On
October 14, 2021, the existing officer resigned immediately, and also will be resigning as a director on the day which is 10 days from
the date of mailing of the Company’s filing of an Information Statement Pursuant to Section 14(f) of the Securities Exchange Act
of 1934 and Rule 14f-1 thereunder. Accordingly, Peter Sohn, serving as a director and an officer, ceased to be the Company’s Chief
Executive Officer, Chief Financial Officer, President, Treasurer, Secretary, and will cease to be a Director on or about October 25,
2021. At the effective date of the transfer, Ying Feng LAI consented to act as the new Chief Executive Officer, Chief Financial Officer,
President, Treasurer, Secretary and a Director of the Company.
Mr.
Ying Feng LAI (“Mr. LAI”), age 30, obtained his Diploma of Business Administration in the Columbia College in Canada in 2012.
From
January 2012 to March 2016, Mr. LAI was an assistant operation commissioner of Aquaporin Industries Limited, a water tech company delivering
innovative technology built on nature’s own water filtration. (“Aquaporin”) Aquaporin had three target markets, namely
industrial water, drinking water and hemodialysis. Mr. LAI was responsible for resources planning and management including hiring and
interviewing, training, coaching, developing, objective setting and performance management.
Since
April 2016, Mr. LAI has been a Vice President of Operation of Zeus Medicine Pharmaceutical Group Limited, a manufacturing company on
branded and generic medicines and medical supplies. (“Zeus”) Mr. LAI is responsible for the leading, developing and mentoring
manufacturing operation.
Mr.
Ying Feng LAI has been appointed as a Chief Executive Officer, Chief Financial Officer, President, Treasurer, Secretary and Directors
of the Company since October 14, 2021.
Item
9.01 Financial Statements and Exhibits.
(d)
Exhibits.
99.1
|
STOCK PURCHASE AGREEMENT, dated September 29, 2021, by and among Peter Sohn and Ying Feng LAI, Wei TJONG, Pak Hong WAN, Johnathan Chung Hon CHOI, Chi Hung YEUNG, and Hau Ming CHOW
|
99.2
|
DIRECTORS RESOLUTIONS, dated October 14, 2021.
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
October
14, 2021
LEGACY
VENTURES INTERNATIONAL, INC.
|
|
|
|
|
|
/s/
Ying Feng LAI
|
|
By:
|
Ying
Feng LAI
|
|
Title:
|
CEO
|
|
Legacy Ventures (CE) (USOTC:LGYV)
Historical Stock Chart
From May 2024 to Jun 2024
Legacy Ventures (CE) (USOTC:LGYV)
Historical Stock Chart
From Jun 2023 to Jun 2024